Why MedAssets buyer is betting on revenue cycle

Buying MedAssets and keeping its revenue-cycle division while shedding the part that makes more money may seem like a smart play for anyone who ever tried to decipher a medical bill.
Modern Healthcare Breaking News

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us